Quanterix Corporation

Alzpath, Inc.

Andreas Jeromin

Linan Song

David Wilson

Lei Chang

Dandan Shan

Edward Kevin Hrusovsky

Carmen Ioana Tobos

Purvish Prahlad Patel

Krish Venkat

Provided herein are compositions and methods relating to improved assays for establishing Alzheimer's disease. Further provided herein are compositions and methods comprising improved antibodies for assays including immunoassays.

Phospho-tau antibodies and methods of use

The present disclosure relates to immunoassays for NF-L performed on liquid samples derived from physiological fluids such as venous blood to detect the presence or absence of a physiological condition by quantifying one or a combination of NF-L determinations at concentrations indicative of the condition.

Quantification of neurofilament light chain in physiological samples

Phospho-TAU antibodies and methods of use

The present disclosure relates to immunoassays for NF-L, GFAP, UCH L1, and Tau performed on liquid samples derived from physiological fluids such as venous blood to detect the presence or absence of a physiological condition by quantifying one or a combination of NF-L, GFAP, UCH L1, and Tau at concentrations indicative of the condition.

Quantification of biomarkers present in physiological samples

The present disclosure relates to digital immunoassays performed on diluted samples obtained from dried blood spots, for example dried capillary blood samples, to detect the presence or absence of a physiological condition by quantifying one or a combination of biomarkers at concentrations indicative of the condition.

Quantification of biomarkers present in dried physiological samples

Growing community of inventors

Alachua, FL, United States of America

Andreas Jeromin